Legislation, Industry, and the Future of Psilocybin for PTSD
The FDA acceptance of Compass Pathway’s Investigational New Drug Application for their COMP360 compound as a possible therapy for PTSD introduces a new area of possible therapies using psilocybin. The post Legislation, Industry, and the Future of Psilocybin for PTSD first appeared on Lucid News. The post Legislation, Industry, and the Future of Psilocybin for PTSD appeared first on Lucid News.
External link. We are not responsible for the content.
Read more ↗More From Lucid News
New Orleans Hosts Psychedelic Research Conference Double-Header
Over the last week in February, more than 200 people from psychedelic drug development companies, clinical researcher...
Turning On The Culture
Author and therapist Charles Wininger asks what would happen if millions of people across the political spectrum aros...
New Federal Bill Aims to Establish VA Office of Novel Therapeutics
The Veterans Health Administration Novel Therapeutics Preparedness Act is the fourth psychedelics-related bill filed ...
Latest News
Psychedelics in the Age of Eco-Anxiety
Eco-anxiety is a rising response to environmental crises that can be transformed into resilience and action through s...
Where Does the World Go to Dance? Probs These EDM Festivals
A global guide to the festivals worth planning for. [...] Read More... The post Where Does the World Go to Dance? Pro...
Inclius Alvarious’s Place Within Indigenous Society
A look at Sonoran Desert toad medicine through the lens of indigenous sovereignty, ecological strain, and the debate ...
Can you kill a bad trip?: 5 Questions for emergency physician Gregory Yates
Yates discusses experimental attempts to end a psychedelic trip early.
Psychedelic Faeries Take on Prohibition and Authoritarianism
Plus psychedelics and telepathy, ego death for the rich, and our brain on Chat GPT [...] Read More... The post Psyche...
Introduction to Trip Sitting
The Art and Science of Holding Psychedelic Space